News in the Life Sciences Industry

UPPSALA, Sweden, Oct. 22, 2018 /PRNewswire/ -- OssDsign AB, the Swedish designer, manufacturer and distributor of regenerative implants for cranial and facial reconstruction, today announced that it has received 510(k) clearance by the US FDA for marketing and sale of its latest product,... Read more ››

STOCKHOLM, Oct. 21, 2018 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA-B) announced today that the European Patent Office (EPO) has issued a decision to grant the company's patent application in Europe, EP09738534.8, for its Parkinson's disease concept patent. The decision states... Read more ››

STOCKHOLM, October 19, 2018 /PRNewswire/ --

GOTHENBURG, Sweden, Oct. 18, 2018 /PRNewswire/ -- "We continue to show strong sales growth, but mix effects have a negative effect on our gross margin", says Mattias Perjos, President & CEO at Getinge. "I am not satisfied that despite higher volumes we have only limited productivity effects... Read more ››

GOTHENBURG, Sweden, Oct. 18, 2018 /PRNewswire/ -- Atrium Medical Corporation, a subsidiary of Getinge, has signed an agreement to divest its biosurgery business to HJ Capital 1, the parent company of SeCQure Surgical Corporation, a global medical device company. The deal is expected to close... Read more ››

STOCKHOLM, Oct. 17, 2018 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR) announced today plans to reduce activities not critical to its development pipeline of drug candidates as part of its enhanced focus on clinical stage projects.

LUND, Sweden, Oct. 17, 2018 /PRNewswire/ --

GÖTEBORG, Sweden, Oct. 16, 2018 /PRNewswire/ -- Capio AB will publish the Interim report for January-September 2018 on Tuesday, October 30 at approximately 08.00 am (CET).

LUND, Sweden, Oct. 16, 2018 /PRNewswire/ -- BioInvent International AB (OMXS: BINV) today announced its intention to initiate three new clinical programs in solid cancer. In addition to the previously disclosed programs (BI-1206 + rituximab - projected topline results H1 2020; and the... Read more ››